Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer)
Annex 2 - Treatment cards for inpatient and outpatient use
Table of contents
- Background
- Growing evidence on the role of specific antibiotics
- Purpose of this document
- Important notes for health workers
- Case definitions3
- When to suspect M. ulcerans disease
- Antibiotics administration and dosages
- Treatment
- Documenting M. ulcerans disease and monitoring response during and after treatment
- Patient information and compliance
- Follow-up after antibiotic treatment
- Reporting of experiences
- Implementation of this guidance
- Monitoring
- Important issues to consider
- Provision of antibiotics
- References
- Annex 1 - Information on rifampicin, streptomycin and amikacin4
- Annex 2 - Treatment cards for inpatient and outpatient use
- Annex 3 - Patient register
- Annex 4 - Follow-up form after antibiotic treatment
- Acknowledgements